Feedback / Questions
QT-019B - Qihan Biotech
https://www.businesswire.com/news/home/20250818100737/en/Qihan-Biotech-Announces-FDA-Clearance-of-IND-for-QT-019B-a-Universal-Dual-Target-CAR-T-Cell-Therapy-for-Refractory-Systemic-Lupus-Erythematosus
Aug 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next